LL-1c
General Information
DRACP ID DRACP02381
Peptide Name LL-1c
Sequence FLGALWHALSHLL
Sequence Length 13
UniProt ID P80399
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP Membrane lysis
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
PANC-1 | Pancreatic ductal adenocarcinoma | Carcinoma | IC50>120 μM | MTT assay | 2 h | 1 |
A549 | Lung adenocarcinoma | Carcinoma | IC50=59 μM | MTT assay | 2 h | 1 |
Hemolytic Activity Human erythrocytes: 0% Hemolysis=30 µM
Normal (non-cancerous) Cytotoxicity MCF-10A: IC50>120 μM
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C73H108N18O15
Absent amino acids CDEIKMNPQRTVY
Common amino acids L
Mass 169202
Pl 7.72
Basic residues 2
Acidic residues 0
Hydrophobic residues 9
Net charge 2
Boman Index 2175
Hydrophobicity 130
Aliphatic Index 165.38
Half Life
Mammalian: 1.1 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 5500
Absorbance 280nm 458.33
Polar residues 2
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 22526264
Title Activity and selectivity of histidine-containing lytic peptides to antibiotic-resistant bacteria
Year 2012
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPS_13995